United States · Bill · S
S. 2227 (118th)
Preventing the Financing of Illegal Synthetic Drugs Act
Introduced
11 July 2023
Last action
—
Status
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2025
Summary
Preventing the Financing of Illegal Synthetic Drugs Act This bill requires the Government Accountability Office to study illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 11 July 2023
Introduced in Senate (PDF)
Introduced in Senate · EN · 11 July 2023
Introduced in Senate
summary · EN · 11 July 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/senate-bill/2227
- Open data entity: https://api.congress.gov/v3/bill/118/s/2227